Abstract
Objective: The dynamic adaptive immune responses elicited by the inactivated virus vaccine CoronaVac remain elusive.
Methods: In a prospective cohort of 100 healthcare professionals naïve for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who received two doses of CoronaVac, we analysed SARS-CoV-2-specific humoral and cellular responses at four different timepoints, including before vaccination (T1), 2 weeks after the first dose (T2), 2 weeks after the booster dose (T3), and 8-10 weeks after the booster dose (T4). SARS-CoV-2-specific antibodies, serum neutralizing activities, peripheral B cells, CD4 + and CD8 + T cells and their memory subsets were simultaneously measured in this cohort.
Results: SARS-CoV-2 spike-specific IgG responses reached a peak (geometric mean titre (GMT) 54827, 30969-97065) after two doses and rapidly declined (GMT 502, 212-1190) at T4, whereas suboptimal IgA responses were detected (GMT 5, 2-9). Spike-specific circulating B cells (0.60%, 0.46-0.73% of total B cells) and memory B cells (1.18%, 0.92-1.44% of total memory B cells) were effectively induced at T3 and sustained over time (0.33%, 0.23-0.43%; 0.87%, 0.05-1.67%, respectively). SARS-CoV-2-specific circulating CD4 + T cells (0.57%, 0.47-0.66%) and CD8 + T cells (1.29%, 1.04-1.54%) were detected at T3. At T4, 0.78% (0.43-1.20%) of memory CD4+ T cells and 0.68% (0.29-1.30%) of memory CD8+ T cells were identified as SARS-CoV-2-specific, while 0.62% (0.51-0.75%) of CD4 + T cells and 0.47% (0.38-0.58%) of CD8 + T cells were SARS-CoV-2-specific terminally differentiated effector memory cells. Furthermore, age and interval between doses affected the magnitude of CoronaVac-induced immune responses. SARS-CoV-2 memory CD4 + T cells were strongly associated with both receptor binding domain (RBD)-specific memory B cells (r 0.87, p <0.0001) and SARS-CoV-2-specific memory CD8 + T cells (r 0.48, p <0.0001).
Conclusions: CoronaVac induced robust circulating and memory B cell and T cell responses. Our study offers new insight into the underlying immunobiology of inactivated virus vaccines in humans and may have implications for vaccine strategies in the future.
Keywords: Adaptive responses; B cells; COVID-19; Inactivated virus vaccine; Neutralization; T cells.
【저자키워드】 COVID-19, T cells, neutralization, B cells, Adaptive responses, Inactivated virus vaccine, 【초록키워드】 severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, Vaccine, coronavirus, vaccination, T cells, neutralization, Human, B cells, CoronaVac, memory B cells, severe acute respiratory syndrome Coronavirus, virus, CD4, CD8, Receptor binding domain, memory, B cell, serum, Cohort, T cell, cells, immune responses, T cell responses, age, Adaptive immune response, prospective cohort, booster dose, SARS-CoV-2-specific antibodies, CD8+ T cell, CD4+ T cell, memory B cell, inactivated, specific antibodies, Healthcare professional, cellular response, dose, humoral, IgG responses, IgG response, geometric mean, acute respiratory syndrome, acute respiratory syndrome coronavirus, first dose, naïve, circulating, neutralizing activities, doses, timepoints, offer, effector memory, IgA response, implication, Cell, memory B, geometric mean titre, peripheral B cells, robust, memory CD4+ T cells, memory CD8+ T cells, terminally differentiated effector memory cells, affected, analysed, magnitude, reached, elicited, subset, sustained, declined, GMT, SARS-CoV-2 spike-specific, terminally differentiated, 【제목키워드】 COVID-19 vaccine, T-cell Response, immunization, inactivated, dynamic, SARS-CoV-2-specific B-cell,